awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q57105258-EF8E5C56-FF21-47E7-92E6-46CA9DE19E3F
Q57105258-EF8E5C56-FF21-47E7-92E6-46CA9DE19E3F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57105258-EF8E5C56-FF21-47E7-92E6-46CA9DE19E3F
Metastatic and triple-negative breast cancer: challenges and treatment options
P2860
Q57105258-EF8E5C56-FF21-47E7-92E6-46CA9DE19E3F
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57105258-EF8E5C56-FF21-47E7-92E6-46CA9DE19E3F
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a25a57a459abd4ddd10c1603c039494049f02282
P2860
A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer